NPY cells were found to significantly decrease in number during early symptom onset and increase in number at end stage of disease suggesting that NPY is involved with, or contributes to, disease processes that evolve within the ALS motor cortex [27]. This evidence concerns the gene NPY and amyotrophic lateral sclerosis.